St Shared Services LLC DBA Keenova Therapeutics (FKA St Shared Services LLC DBA
Based in MO
AI Overview
With $8.4M in lobbying spend across 35 quarterly filings, St Shared Services LLC DBA Keenova Therapeutics (FKA St Shared Services LLC DBA is one of the biggest lobbying spenders in Washington. Their lobbying covers 6 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $1.6M |
| 2019 | $820K |
| 2020 | $1.6M |
| 2021 | $1.3M |
| 2022 | $1.0M |
| 2023 | $680K |
| 2024 | $770K |
| 2025 | $640K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that St Shared Services LLC DBA Keenova Therapeutics (FKA St Shared Services LLC DBA disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Copyright/Patent, Health Issues, Pharmacy, Medicare/Medicaid, Budget/Appropriations and 1 more
Innovation ACT (H.R.9); Issues related to patents.
Issues related to Medicare and opioids; Issues related to BARDA funding; Appropriations
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number); Issues related to Medicare and M
340B (no specific bill); Issues related to Medicare generally.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.